HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

FDA approves tesamorelin for HIV-related lipodystrophy.

AuthorsKate Traynor
JournalAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists (Am J Health Syst Pharm) Vol. 67 Issue 24 Pg. 2082 (Dec 15 2010) ISSN: 1535-2900 [Electronic] England
PMID21115997 (Publication Type: News)
Chemical References
  • Growth Hormone-Releasing Hormone
  • tesamorelin
Topics
  • Abdominal Fat (drug effects)
  • Drug Approval
  • Growth Hormone-Releasing Hormone (adverse effects, analogs & derivatives, therapeutic use)
  • HIV-Associated Lipodystrophy Syndrome (drug therapy)
  • Humans
  • United States
  • United States Food and Drug Administration

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: